April 28, 2025 | This email address is being protected from spambots. You need JavaScript enabled to view it. - A new collaboration bringing entrepreneurs and investors together with physician-scientists, surgeons, and medical technologists promises to launch the Baltimore region as a major national hub for new biomedical ventures and start-up companies. The initiative, called the “Innovation Alliance,” leverages the region's national and international leadership in biomedical research and technology to attract venture capital, foster startups, drive economic growth, and ultimately bring to market new treatments, cures, and technologies that will directly improve lives.
Shape of the Alliance
The Innovation Alliance will have three main components centered around funding and support for innovators as they take ideas from the lab to the marketplace. These include gathering twice a year to give partners and investors an exclusive first look at new technologies and emerging businesses supported and reviewed by the life sciences accelerator University of Maryland Baltimore Life Science Discovery (UM-BILD). Alliance partners will also work with an Innovation Advisory Group to review and consult on grant and investment decisions for cultivating new biomedical projects. Lastly, members of this new partnership will offer mentorship for university-affiliated researchers with entrepreneurial ideas.
“Our vision of the new Innovation Alliance is an open, collaborative network where members can invite potential partners to accelerate healthcare innovation,” said Mark T. Gladwin, MD, Dean of the University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, Baltimore (UMB), and the John Z. and Akiko K. Bowers Distinguished Professor. “Together, we can drive transformative medical solutions to improve patient care, advance scientific discovery, and position Maryland as a global leader and in the med-tech space.”
Click here to continue reading.